Literature DB >> 7646593

[Prevalence of obesity in Spain].

J L Gutiérrez-Fisac1, E Regidor, C Rodríguez.   

Abstract

BACKGROUND: Obesity constitutes a severe public health problem due to both its complications as a morbid entity and its association to different chronic diseases. The aim of the present study was to calculate the prevalence of obesity in the Spanish adult population.
METHODS: With the information concerning weight and height of a representative population sample of Spanish adults over the age of 20 obtained from the computerized data base of the National Survey of Spanish Public Health, Quetelet's index was calculated as an estimation of obesity.
RESULTS: 7.8% of the Spanish adult population may be considered as obese. Obesity is more frequent in individuals from 55 to 64 years of age, in females and in those with a lower education.
CONCLUSIONS: From estimations performed from self declared data concerning weight and height, obesity was found to be more frequent in the population from 45 to 74 years of age, in females and in those of low socioeconomic levels.

Entities:  

Mesh:

Year:  1994        PMID: 7646593

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  3 in total

1.  Energy expenditure during leisure time and body mass index in Spain.

Authors:  S Martín-Almendros; M A Martínez-González; J De Irala-Estévez; M J Gibney; J Kearney; J A Martínez
Journal:  J Physiol Biochem       Date:  2000-06       Impact factor: 4.158

2.  [Cardiovascular risk factors: a follow up study in a non-diabetic population].

Authors:  María Vernet Vernet; María José Sender Palacios; Esther Jovell Fernández; Encarnació Tor Figueras; Ramón Casals Riera; Pere Larrosa Sàez
Journal:  Aten Primaria       Date:  2009-08-06       Impact factor: 1.137

3.  Prevalence of obesity in south-east Spain and its relation with social and health factors.

Authors:  F Soriguer; G Rojo-Martínez; I Esteva de Antonio; M S Ruiz de Adana; M Catalá; M J Merelo; M Beltrán; F J Tinahones
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.